RNA interference toward MMP-2 may be an effective therapeutic strategy for cancer

Mar 09, 2009

The invasion or metastasis of pancreatic cancer has been known to be a complex process involving many molecular mechanisms, of which proteolytic degradation of extracellular matrix (ECM) exerted by matrix metalloproteinases (MMPs) was considered to be an essential step. Some data suggest that MMP-2 is involved in pancreatic cancer invasion and metastasis, and a high level of MMP-2 has been found to correlate with poor prognosis in patients with pancreatic cancer. Therefore, inhibition of MMP-2 may be of great value in both preventing pancreatic cancer and blocking metastasis of established tumors.

A study will be published on March 7, 2009 address the question. The research team led by Professor Song from Department of General Surgery, Affiliated Beijing Tiantan Hospital, Capital Medical University utilized system by using the vector (pGPU6)to specifically knock down MMP-2 expression in cell. MMP-2 expression was measured by reverse transcription polymerase chain reaction (RT-PCR) and Western blot. Cell proliferation, apoptosis were examined by MTT, flow cytometry, respectively. The abilities of adhesion and invasion were detected by cell adhesion assay and cell invasion assay using Transwell chambers.

Data provide evidence that RNA interference against MMP-2 successfully inhibited the mRNA and protein expression of MMP-2 in the pancreatic cancer line Bxpc-3, leading to a potent suppression of tumor cells adhesion and invasion without affecting cells proliferation and apoptosis. These findings suggest that RNA interference towards MMP-2 may be an effective therapeutic strategy for the clinical management of pancreatic tumor. Although the leap to clinical practice remains elusive, gene therapy targeting MMP-2 is attractive and warrants further investigation.

More information: Zhi YH, Song MM, Wang PL, Zhang T, Yin ZY. Suppression of matrix metalloproteinase-2 via RNA interference inhibits pancreatic carcinoma cell invasiveness and adhesion. World J Gastroenterol 2009; 15(9): 1072-1078, www.wjgnet.com/1007-9327/15/1072.asp

Source: World Journal of Gastroenterology

Explore further: Endogenous hormones improve breast cancer risk models

add to favorites email to friend print save as pdf

Related Stories

Study provides clues to prevent spread of ovarian cancer

Mar 13, 2008

A drug that blocks production of an enzyme that enables ovarian cancer to gain a foothold in a new site can slow the spread of the disease and prolong survival in mice, according to a study by researchers from the University ...

Recommended for you

Endogenous hormones improve breast cancer risk models

15 minutes ago

(HealthDay)—Inclusion of endogenous hormones in prediction models improves prediction of invasive breast cancer risk in postmenopausal women, according to a study published online Aug. 18 in the Journal of ...

Novel oncogenic RET mutation found in small cell lung cancer

1 hour ago

For the first time an oncogenic somatic mutation at amino acid 918 in the RET (rearranged during transfection) protein has been identified in small cell lung cancer (SCLC) tumors and enforced expression of this mutation within ...

User comments : 2

Adjust slider to filter visible comments by rank

Display comments: newest first

E_L_Earnhardt
1 / 5 (1) Mar 09, 2009
The worst cancer of the lot! Even THAT one would fall if doctors in the field were allowed to use their brains! Freeze and transplant comes to mind! Cool and inject a new electronic program or just thaw slowly if none is available!> Drugs don't work!
NeilFarbstein
1 / 5 (1) Mar 10, 2009
I have been working on this method of stopping metastasis a long time. 15 years or longer.